Yes Gekkowolf we been hearing about FDA for years now but with every other bio stock I've had , an application for FDA comes with a timeline for approval or rejection with a known date for the decision to be given by. So I don't believe anything will come of the US market for years if ever. We can only hope revenue from sales can increase to extend the time the cash from this raise long enough to finish trials but it doesn't seem like patients are queuing up to join the trials even for what I assume is a free or subsidised treatment which is a concern.
OSL Price at posting:
0.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)